Jeffrey B. King, MD

Special Interests

Colon cancer prevention, hereditary colorectal cancer syndromes, celiac disease, eosinophilic esophagitis, motility disorders, pelvic floor dysfunction, inflammatory bowel disease, functional GI disorders/irritable bowel syndrome, gastroesophageal reflux disease, Barrett's esophagus, fatty liver disease, viral hepatitis, alcoholic liver disease.

Education

Education

2001 - 2005

University of Massachusetts Medical School

1995 - 1999

Duke University

Residency

2008 - 2009

Boston University Medical Center, Chief Resident

2005 - 2008

Boston University Medical Center

Fellowship

2010 - 2014

University of North Carolina at Chapel Hill

Awards & Recognition

2014: UNC Award for Excellence in Clinical Gastroenterology
2012: Ad Hoc reviewer for American Journal of Physiology - Gastrointestinal and Liver Physiology

Board Certification

2008: Internal Medicine

Professional Memberships

American Gastroenterological Association
American Society for Gastrointestinal Endoscopy

Publications

King JB, von Furstenberg RJ, Smith BJ, McNaughton KK, Galanko JA, Henning SJ. CD24 can be used to isolate Lgr5+ putative colonic epithelial stem cells in mice. Am J Physiol Gastrointest Liver Physiol. 303(4): G442-52, 2012.

Conflicts of Interest

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.